Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 6/20 | 0.59 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TNF | P01375 | 1/20 | 0.45 |
| ▸ | GJB2 | P29033 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | TK2 | O00142 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28069563 | 1.00 | GBA1 (0.59) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL28066817 | 1.00 | GBA1 (0.59) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL27938366 | 1.00 | GBA1 (0.59) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL28066824 | 1.00 | GBA1 (0.59) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL28069583 | 1.00 | GBA1 (0.59) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL16678919 | 0.95 | SLC2A1 (0.58) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL14500937 | 0.94 | SLC2A1 (0.52) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL16377619 | 0.94 | SLC2A1 (0.52) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL16678933 | 0.94 | SLC2A1 (0.56) | GBA1SLC2A1MAPK1TNFGJB2 | |
| SCHEMBL16330459 | 0.94 | SLC2A1 (0.52) | GBA1SLC2A1MAPK1TNFGJB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0338265-B1 | Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine | AMERICAN CYANAMID CO (US) | 1994-05-04 | — | — | EP | claimed |